DXR - יחס חוב להיוון בספרים Daxor

Daxor Corporation partners with intensive care units to implement blood volume monitoring methods. The share of debt financing in the balance sheet capitalization confirms the resilience of this strategy, where 0.00 is the current level of the indicator. The consumables sales model ensures a steady cash flow, while a focus on niche markets has stabilized production costs, creating a foundation for further growth.

The ratio is calculated as total liabilities divided by the market value of equity. This metric determines the actual financial leverage, where daily stock price action adjusts the debt load level. For Daxor Corporation (DXR), this balance is critical when implementing cardiology standards and scaling the sales of consumables. The dynamic trend of financial leverage on the balance sheet visualizes the company's resilience to cash flow gaps. Investors should assess risk through the ratio of credit pressure to market demand.